AU612589B2 - Nasal pharmaceutical composition containing a somatostatin analogue - Google Patents

Nasal pharmaceutical composition containing a somatostatin analogue

Info

Publication number
AU612589B2
AU612589B2 AU77120/87A AU7712087A AU612589B2 AU 612589 B2 AU612589 B2 AU 612589B2 AU 77120/87 A AU77120/87 A AU 77120/87A AU 7712087 A AU7712087 A AU 7712087A AU 612589 B2 AU612589 B2 AU 612589B2
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
composition containing
somatostatin analogue
nasal pharmaceutical
nasal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU77120/87A
Other languages
English (en)
Other versions
AU7712087A (en
Inventor
Moise Azria
Thomas Cavanak
Wolfgang Doepfner
Andreas Rummelt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620035A external-priority patent/GB8620035D0/en
Priority claimed from GB868626821A external-priority patent/GB8626821D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU7712087A publication Critical patent/AU7712087A/en
Application granted granted Critical
Publication of AU612589B2 publication Critical patent/AU612589B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU77120/87A 1986-08-18 1987-08-17 Nasal pharmaceutical composition containing a somatostatin analogue Ceased AU612589B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868620035A GB8620035D0 (en) 1986-08-18 1986-08-18 Organic compounds
GB8620035 1986-08-18
GB8626821 1986-11-10
GB868626821A GB8626821D0 (en) 1986-11-10 1986-11-10 Organic compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU85689/91A Division AU637530B2 (en) 1986-08-18 1991-10-09 Novel galenical formulations

Publications (2)

Publication Number Publication Date
AU7712087A AU7712087A (en) 1988-02-25
AU612589B2 true AU612589B2 (en) 1991-07-18

Family

ID=26291187

Family Applications (2)

Application Number Title Priority Date Filing Date
AU77120/87A Ceased AU612589B2 (en) 1986-08-18 1987-08-17 Nasal pharmaceutical composition containing a somatostatin analogue
AU85689/91A Ceased AU637530B2 (en) 1986-08-18 1991-10-09 Novel galenical formulations

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU85689/91A Ceased AU637530B2 (en) 1986-08-18 1991-10-09 Novel galenical formulations

Country Status (24)

Country Link
KR (1) KR880002537A (de)
AT (1) AT396331B (de)
AU (2) AU612589B2 (de)
BE (1) BE1001748A4 (de)
CA (1) CA1322331C (de)
CH (1) CH672252A5 (de)
CS (1) CS411491A3 (de)
DE (1) DE3726517A1 (de)
DK (1) DK428287A (de)
ES (1) ES2004807A6 (de)
FI (1) FI93307C (de)
FR (1) FR2602680B1 (de)
GR (1) GR871289B (de)
HK (1) HK80493A (de)
HU (1) HU200940B (de)
IE (1) IE60761B1 (de)
IL (1) IL83572A (de)
IT (1) IT1222510B (de)
LU (1) LU86971A1 (de)
NL (1) NL8701874A (de)
NO (1) NO175519C (de)
NZ (1) NZ221473A (de)
PT (1) PT85545B (de)
SE (1) SE8703183L (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003061592A2 (en) 2002-01-22 2003-07-31 New York University Methods for therapeutic treatment of benign prostatic hypertrophy (bph)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
ATE2512T1 (de) * 1979-11-27 1983-03-15 Sandoz Ag Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung.
US4451394A (en) * 1982-10-25 1984-05-29 American Home Products Corporation Dodecapeptides preventing glucose and triglyceride assimilation
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4505897A (en) * 1983-04-18 1985-03-19 The Administrators Of The Tulane Educational Fund Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体

Also Published As

Publication number Publication date
AU637530B2 (en) 1993-05-27
AT396331B (de) 1993-08-25
FI873548A (fi) 1988-02-19
IL83572A (en) 1992-09-06
KR880002537A (ko) 1988-05-09
FI873548A0 (fi) 1987-08-17
NL8701874A (nl) 1988-03-16
NZ221473A (en) 1990-08-28
PT85545B (pt) 1990-05-31
NO175519C (no) 1994-10-26
HUT46235A (en) 1988-10-28
IT8721670A0 (it) 1987-08-18
IE60761B1 (en) 1994-08-10
DE3726517A1 (de) 1988-03-03
HK80493A (en) 1993-08-13
FR2602680A1 (fr) 1988-02-19
CS411491A3 (en) 1992-06-17
DK428287D0 (da) 1987-08-17
IE872187L (en) 1988-02-18
NO873452D0 (no) 1987-08-17
BE1001748A4 (fr) 1990-02-27
NO175519B (no) 1994-07-18
PT85545A (en) 1987-09-01
IT1222510B (it) 1990-09-05
SE8703183L (sv) 1988-02-19
HU200940B (en) 1990-09-28
LU86971A1 (fr) 1988-03-02
FR2602680B1 (fr) 1993-04-16
IL83572A0 (en) 1988-01-31
FI93307B (fi) 1994-12-15
ES2004807A6 (es) 1989-02-01
AU7712087A (en) 1988-02-25
CH672252A5 (de) 1989-11-15
DK428287A (da) 1988-02-19
CA1322331C (en) 1993-09-21
SE8703183D0 (sv) 1987-08-17
GR871289B (en) 1987-12-18
FI93307C (fi) 1995-03-27
AU8568991A (en) 1991-12-05
NO873452L (no) 1988-02-19
ATA206087A (de) 1992-12-15

Similar Documents

Publication Publication Date Title
AU561463B2 (en) A pharmaceutical formulation containing azapropazone
NZ215737A (en) Intranasal pharmaceutical compositions containing insulin
GB8613688D0 (en) Pharmaceutical composition
GB2193891B (en) Nasal pharmaceutical composition containing a somatostatin anologue.
IL87044A0 (en) Pharmaceutical compositions comprising somatostatin analogues
GB8906584D0 (en) Nasal pharmaceutical compositions
AU7336487A (en) Pharmaceutical compositions
AU607451B2 (en) Pharmaceutical compositions
IL90639A (en) Neplanocin derivatives and analogs and pharmaceutical compositions containing them
AU7939487A (en) Pharmaceutical compositions
IL87943A (en) Pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
GB8628373D0 (en) Pharmaceutical composition
AU612589B2 (en) Nasal pharmaceutical composition containing a somatostatin analogue
AU585890B2 (en) Pharmaceutical use of somatostatin analogues
AU8292987A (en) Pharmaceutical compositions
GB8614189D0 (en) Pharmaceutical composition
IL79195A0 (en) Pharmaceutical compositions containing a styrylnaphthalene derivative
AU587505B2 (en) Pharmaceutical compositions
AU3298589A (en) New pharmaceutical composition
GB8621008D0 (en) Pharmaceutical composition
IL79194A0 (en) Pharmaceutical compositions containing a styrylnaphthalene derivative
AU7819887A (en) Pharmaceutical composition
IE861461L (en) Nasal pharmaceutical composition
IL83177A0 (en) Pharmaceutical compositions containing xylometazoline
IL86030A0 (en) Pharmaceutical compositions containing a certain steroid